Atresmedia sells its 5% stake in Fever Labs for 227 million euros

Atresmedia Corporación has completed the sale of its remaining 5% stake in the Spanish technology platform Fever Labs to Vitruvian Partners for approximately 227 million euros. This transaction results in a net profit after taxes of 205 million euros for Atresmedia.

Following previous partial divestments in 2023 and 2024, Atresmedia’s total revenue from Fever sales has reached 296 million euros, generating a total after-tax profit of 264 million euros. The company noted that the sale concludes an investment process that has created significant value through Fever's international expansion in the leisure and entertainment sectors.

The sale of this stake places Fever's valuation at over 4.5 billion euros. Market sources indicate that Fever is preparing for a new funding round, potentially involving the Swedish private equity firm EQT, which could reach approximately 200 million euros. Other notable shareholders in Fever include Goldman Sachs and L Catterton. While the company has previously considered an initial public offering (IPO), it currently appears to be focusing on raising capital through private rounds.